"pancreatic disorders" trang 2 - tải miễn phí từ tailieuXANH
R269C variant of ESR1: High prevalence and differential function in a subset of pancreatic cancers

R269C variant of ESR1: High prevalence and differential function in a subset of pancreatic cancers
15    73    0
Opinions and use of neoadjuvant therapy for resectable, borderline resectable, and locally advanced pancreatic cancer: International survey and case-vignette study

Opinions and use of neoadjuvant therapy for resectable, borderline resectable, and locally advanced pancreatic cancer: International survey and case-vignette study
9    99    0
Serum gamma-glutamyltransferase and the overall survival of metastatic pancreatic cancer

Serum gamma-glutamyltransferase and the overall survival of metastatic pancreatic cancer
7    111    0
Surgery for elderly patients with resectable pancreatic cancer, a comparison with nonsurgical treatments: A retrospective study outcomes of resectable pancreatic cancer

Surgery for elderly patients with resectable pancreatic cancer, a comparison with nonsurgical treatments: A retrospective study outcomes of resectable pancreatic cancer
7    76    0
Novel biomarkers distinguishing pancreatic head Cancer from distal cholangiocarcinoma based on proteomic analysis

Novel biomarkers distinguishing pancreatic head Cancer from distal cholangiocarcinoma based on proteomic analysis
10    81    0
Deficiency in hormone-sensitive lipase accelerates the development of pancreatic cancer in conditional KrasG12D mice

Deficiency in hormone-sensitive lipase accelerates the development of pancreatic cancer in conditional KrasG12D mice
9    67    0
PET/CT incidental detection of second tumor in patients investigated for pancreatic neoplasms

PET/CT incidental detection of second tumor in patients investigated for pancreatic neoplasms
7    72    0
Histone profiling reveals the H1.3 histone variant as a prognostic biomarker for pancreatic ductal adenocarcinoma

Histone profiling reveals the H1.3 histone variant as a prognostic biomarker for pancreatic ductal adenocarcinoma
9    70    0
A non-controlled, single arm, open label, phase II study of intravenous and intratumoral administration of ParvOryx in patients with metastatic, inoperable pancreatic cancer: ParvOryx02 protocol

A non-controlled, single arm, open label, phase II study of intravenous and intratumoral administration of ParvOryx in patients with metastatic, inoperable pancreatic cancer: ParvOryx02 protocol
11    89    0
Global targetome analysis reveals critical role of miR-29a in pancreatic stellate cell mediated regulation of PDAC tumor microenvironment

Global targetome analysis reveals critical role of miR-29a in pancreatic stellate cell mediated regulation of PDAC tumor microenvironment
13    102    0
Long-term outcomes and significance of preoperative lymphocyte-to-monocyte ratio as a prognostic indicator in patients with invasive pancreatic neoplasms after repeat pancreatectomy

Long-term outcomes and significance of preoperative lymphocyte-to-monocyte ratio as a prognostic indicator in patients with invasive pancreatic neoplasms after repeat pancreatectomy
9    48    0
S100A8 and S100A9 proteins form part of a paracrine feedback loop between pancreatic cancer cells and monocytes

S100A8 and S100A9 proteins form part of a paracrine feedback loop between pancreatic cancer cells and monocytes
8    88    0
Real world evidence on gemcitabine and nab-paclitaxel combination chemotherapy in advanced pancreatic cancer

Real world evidence on gemcitabine and nab-paclitaxel combination chemotherapy in advanced pancreatic cancer
9    53    0
Expression of estrogen receptor beta correlates with adverse prognosis in resected pancreatic adenocarcinoma

Expression of estrogen receptor beta correlates with adverse prognosis in resected pancreatic adenocarcinoma
9    63    0
Triptolide as a novel agent in pancreatic cancer: The validation using patient derived pancreatic tumor cell line

Triptolide as a novel agent in pancreatic cancer: The validation using patient derived pancreatic tumor cell line
7    74    0
Calcium-activated chloride channel regulator 1 as a prognostic biomarker in pancreatic ductal adenocarcinoma

Calcium-activated chloride channel regulator 1 as a prognostic biomarker in pancreatic ductal adenocarcinoma
6    67    0
Diagnostic accuracy of contrast-enhanced diffusion-weighted MRI for liver metastases of pancreatic cancer: Towards adequate staging and follow-up of pancreatic cancer – DIA-PANC study: Study protocol for an international, multicenter, diagnostic trial

Diagnostic accuracy of contrast-enhanced diffusion-weighted MRI for liver metastases of pancreatic cancer: Towards adequate staging and follow-up of pancreatic cancer – DIA-PANC study: Study protocol for an international, multicenter, diagnostic trial
8    73    0
Incorporating Yttrium-90 trans-arterial radioembolization (TARE) in the treatment of metastatic pancreatic adenocarcioma: A single center experience

Incorporating Yttrium-90 trans-arterial radioembolization (TARE) in the treatment of metastatic pancreatic adenocarcioma: A single center experience
7    69    0
NAB-paclitaxel and gemcitabine in metastatic pancreatic ductal adenocarcinoma (PDAC): From clinical trials to clinical practice

NAB-paclitaxel and gemcitabine in metastatic pancreatic ductal adenocarcinoma (PDAC): From clinical trials to clinical practice
8    82    0
The anti-oxidative transcription factor Nuclear factor E2 related factor-2 (Nrf2) counteracts TGF-β1 mediated growth inhibition of pancreatic ductal epithelial cells -Nrf2 as determinant of pro-tumorigenic functions of TGF-β1

The anti-oxidative transcription factor Nuclear factor E2 related factor-2 (Nrf2) counteracts TGF-β1 mediated growth inhibition of pancreatic ductal epithelial cells -Nrf2 as determinant of pro-tumorigenic functions of TGF-β1
14    55    0
Đã phát hiện trình chặn quảng cáo AdBlock
Trang web này phụ thuộc vào doanh thu từ số lần hiển thị quảng cáo để tồn tại. Vui lòng tắt trình chặn quảng cáo của bạn hoặc tạm dừng tính năng chặn quảng cáo cho trang web này.